The Treatment of Patients with Advanced Heart Failure Ineligible for Cardiac Transplantation with the HeartWare Ventricular Assist Device: Results of the ENDURANCE Supplement Trial
Carmelo A. Milano(Duke University Hospital), Francis D. Pagani(Michigan Medicine), Mark S. Slaughter(University of Louisville), Claudius Mahr(Medical City Dallas Hospital), Emma J. Birks(Lung Institute), Joni Miller(Emory Healthcare), Katrin Leadley(Heartware International (United States)), Valluvan Jeevanandam(University of Chicago), Antone Tatooles(Rush University Medical Center), Keith D. Aaronson(University of Michigan), G. Bhat(Advocate Health Care), Joseph G. Rogers(Baylor College of Medicine), Nahush A. Mokadam(University of Washington)
Cited by 14
Related Papers
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711
Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation
|Circulation|2012|655
Continuous Flow Left Ventricular Assist Device Improves Functional Capacity and Quality of Life of Advanced Heart Failure Patients
|Journal of the American College of Cardiology|2010|583